{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:36:01Z","timestamp":1764401761182,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T00:00:00Z","timestamp":1508457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ijid.2017.10.010","type":"journal-article","created":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T09:45:30Z","timestamp":1511775930000},"page":"137-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Immunogenicity and safety of a single dose of a live attenuated Japanese encephalitis chimeric virus vaccine in Vietnam: A single-arm, single-center study"],"prefix":"10.1016","volume":"66","author":[{"given":"Thiem Dinh","family":"Vu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quang Dang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huong Thi Ai","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Bosch-Castells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Zocchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Houillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ijid.2017.10.010_bib0005","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2471\/BLT.10.085233","article-title":"Estimated global incidence of Japanese encephalitis: a systematic review","volume":"89","author":"Campbell","year":"2011","journal-title":"Bull World Health Organ"},{"issue":"12","key":"10.1016\/j.ijid.2017.10.010_bib0010","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/INF.0b013e3181f68e9c","article-title":"Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial","volume":"29","author":"Chokephaibulkit","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.ijid.2017.10.010_bib0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1586\/14760584.2016.1123097","article-title":"Safety and immunogenicity of a live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV(R)) in children","volume":"15","author":"Chokephaibulkit","year":"2016","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.ijid.2017.10.010_bib0020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.vaccine.2016.11.062","article-title":"Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand","volume":"35","author":"Chotpitayasunondh","year":"2017","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.ijid.2017.10.010_bib0025","doi-asserted-by":"crossref","first-page":"929","DOI":"10.4161\/hv.20071","article-title":"Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12\u201318 months: randomized, controlled phase 3 immunogenicity and safety trial","volume":"8","author":"Feroldi","year":"2012","journal-title":"Hum Vaccines Immunother"},{"issue":"4","key":"10.1016\/j.ijid.2017.10.010_bib0030","doi-asserted-by":"crossref","first-page":"889","DOI":"10.4161\/hv.23087","article-title":"Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children","volume":"9","author":"Feroldi","year":"2013","journal-title":"Hum Vaccines Immunother"},{"issue":"6","key":"10.1016\/j.ijid.2017.10.010_bib0035","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/INF.0000000000000276","article-title":"Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety","volume":"33","author":"Feroldi","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.ijid.2017.10.010_bib0040","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/tropej\/fmp133","article-title":"Disability from Japanese encephalitis in Cambodia and Viet Nam","volume":"57","author":"Hills","year":"2010","journal-title":"J Trop Pediatr"},{"issue":"45","key":"10.1016\/j.ijid.2017.10.010_bib0045","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","article-title":"Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2\u20133 September, 2004","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"issue":"41","key":"10.1016\/j.ijid.2017.10.010_bib0050","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1016\/j.vaccine.2014.02.085","article-title":"Concomitant administration of live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) and measles, mumps, rubella (MMR) vaccine: randomized study in toddlers in Taiwan","volume":"32","author":"Huang","year":"2014","journal-title":"Vaccine"},{"issue":"44","key":"10.1016\/j.ijid.2017.10.010_bib0055","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.1016\/j.vaccine.2016.09.005","article-title":"Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children","volume":"34","author":"Janewongwirot","year":"2016","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.ijid.2017.10.010_bib0060","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.4161\/hv.29743","article-title":"A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea","volume":"10","author":"Kim","year":"2014","journal-title":"Hum Vaccines Immunother"},{"issue":"4","key":"10.1016\/j.ijid.2017.10.010_bib0065","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1097\/INF.0000000000001494","article-title":"Long-term immunogenicity of a single dose of Japanese encephalitis chimeric virus vaccine in toddlers and booster response 5 years after primary immunization","volume":"36","author":"Kosalaraksa","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.ijid.2017.10.010_bib0070","doi-asserted-by":"crossref","first-page":"e1952","DOI":"10.1371\/journal.pntd.0001952","article-title":"Effectiveness of the Viet Nam produced, mouse brain-derived, inactivated Japanese encephalitis vaccine in Northern Viet Nam","volume":"6","author":"Marks","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"10.1016\/j.ijid.2017.10.010_bib0075","doi-asserted-by":"crossref","first-page":"906","DOI":"10.4161\/hv.6.11.12854","article-title":"Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity","volume":"6","author":"Nasveld","year":"2010","journal-title":"Hum Vaccines"},{"issue":"8","key":"10.1016\/j.ijid.2017.10.010_bib0080","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","article-title":"Two-sided confidence intervals for the single proportion: comparison of seven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.ijid.2017.10.010_bib0085","first-page":"120","article-title":"An epidemiological review of Japanese encephalitis","volume":"31","author":"Okuno","year":"1978","journal-title":"World Health Stat Q"},{"issue":"1","key":"10.1016\/j.ijid.2017.10.010_bib0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00415-011-6131-9","article-title":"Japanese encephalitis (JE) part II: 14 years\u2019 follow-up of survivors","volume":"259","author":"Sarkari","year":"2012","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.ijid.2017.10.010_bib0095","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/jnnp.68.4.405","article-title":"Japanese encephalitis","volume":"68","author":"Solomon","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"50","key":"10.1016\/j.ijid.2017.10.010_bib0100","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.1016\/j.vaccine.2010.09.035","article-title":"Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: randomised controlled phase 3 trials","volume":"28","author":"Torresi","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2017.10.010_bib0105","first-page":"435","article-title":"Epidemiology of Japanese encephalitis: past, present, and future prospects","volume":"11","author":"Wang","year":"2015","journal-title":"Ther Clin Risk Manag"},{"issue":"34\/35","key":"10.1016\/j.ijid.2017.10.010_bib0110","first-page":"331","article-title":"Japanese encephalitis vaccines","volume":"81","author":"World Health Organization","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"issue":"4","key":"10.1016\/j.ijid.2017.10.010_bib0115","doi-asserted-by":"crossref","first-page":"816","DOI":"10.4269\/ajtmh.2010.10-0262","article-title":"Surveillance for Japanese encephalitis in Vietnam, 1998\u20132007","volume":"83","author":"Yen","year":"2010","journal-title":"Am J Trop Med Hyg"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971217302667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971217302667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:39:43Z","timestamp":1761118783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971217302667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":23,"alternative-id":["S1201971217302667"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2017.10.010","relation":{},"ISSN":["1201-9712"],"issn-type":[{"type":"print","value":"1201-9712"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of a single dose of a live attenuated Japanese encephalitis chimeric virus vaccine in Vietnam: A single-arm, single-center study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2017.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}